Tanl power point
•Download as PPT, PDF•
0 likes•2 views
The study aimed to examine respiratory diseases in newborns, especially respiratory distress syndrome (RDS), and the relationship between gestational age, birth weight and RDS. It analyzed 30 newborns admitted to the neonatal intensive care unit and department from January to February 2008. The findings were that RDS predominantly affects preterm infants under 32 weeks gestation. Treatment for RDS included surfactant therapy, CPAP, ventilation and antibiotics. Combinations and durations of antibiotics depended on the diagnosis and severity of the condition.
Report
Share
Report
Share
![Objectives of the study ,[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Asthma in pregnancy
asthma in pregnancy is a common medical disorder of great interest, especially with its raising prevalence
Asthma in pregnancy
Asthma during pregnancy differs from non-pregnancy due to immunological, hormonal and respiratory changes. Approximately 1/3 of asthmatic women experience improved symptoms, 1/3 similar symptoms, and 1/3 worse symptoms. Factors like respiratory infections, obesity, and lack of medication adherence can increase risk of exacerbation. Proper asthma management and treatment is important to minimize risks to both mother and fetus.
Asthma in pregnancy
Topics covere
*difference b/w normal and asthmatic bronchi
*Triggering factors
* Respiratory changes during pregnancy
*Effects of asthma on pregnancy
* Pregnancy outcomes
* Clinical features
*Examination
*Management
*Complications
Asthma in Pregnancy
This document discusses asthma in pregnancy. It begins by introducing asthma as a common condition that affects approximately 8% of pregnant women. Left uncontrolled, asthma can increase risks of adverse pregnancy outcomes. The document then covers evaluation and diagnosis of asthma during pregnancy, including physical exams, symptoms, pulmonary function tests, and differentiating normal pregnancy dyspnea. It discusses management of asthma through education, monitoring, and medication including inhaled corticosteroids and beta-agonists. The goal of treatment is prevention of exacerbations to avoid risks to maternal and fetal health.
Asthma in pregnancy
1) Asthma affects approximately 4-8% of pregnant women. While pregnancy does not typically impair lung function, it can intensify the effects of lung diseases like asthma.
2) The pathophysiology of asthma involves chronic airway inflammation from factors like allergens, viruses, and environmental irritants. During pregnancy, changes in lung volumes and capacities can increase a woman's risk of hypoxia from asthma exacerbations.
3) For chronic asthma, treatment focuses on education, environmental control, and pharmacological therapy like inhaled corticosteroids and bronchodilators to maintain lung function. For acute exacerbations, therapy aims to quickly reverse bronchoconstriction and prevent
Asthma in pregnancy
- Asthma is characterized by airway inflammation and constriction caused by various triggers that vary between individuals. Common triggers include allergens, viruses, smoke, and exercise.
- The course of asthma during pregnancy is unpredictable, with symptoms improving in some, worsening in others, and no change in the remaining third. Poorly controlled asthma is associated with increased risks for complications.
- Most asthma medications are considered low risk during pregnancy and breastfeeding. Corticosteroids should not be withheld due to safety concerns. Acute asthma attacks during pregnancy require prompt treatment including oxygen, fluids, bronchodilators, and corticosteroids.
Astma in pregnancy
This document discusses the management of asthma during pregnancy. It notes that asthma is common in pregnancy, with respiratory changes occurring due to anatomical and hormonal factors. Pregnancy can affect asthma severity, with courses varying between women. Well controlled asthma is important for limiting risks to the pregnancy. Treatment follows a stepwise approach, initially using inhaled corticosteroids. Close monitoring is needed to prevent exacerbations while minimizing medication risks for the fetus. Inhaled beta-agonists are generally considered safe options for relief of symptoms during pregnancy.
Asthma in Pregnancy
This document discusses asthma in pregnancy. It defines asthma as a chronic inflammatory disease of the airways characterized by variable airflow limitation and respiratory symptoms. The prevalence of asthma in pregnancy ranges from 1-4%. The document outlines the risks of uncontrolled asthma in pregnancy, including preeclampsia, preterm birth, and low birth weight. It also covers the pathophysiology of asthma and how pregnancy affects respiratory physiology. Examination findings, differential diagnoses, diagnostic tests, treatment options, and management of asthma during pregnancy are discussed in detail.
Recommended
Asthma in pregnancy
asthma in pregnancy is a common medical disorder of great interest, especially with its raising prevalence
Asthma in pregnancy
Asthma during pregnancy differs from non-pregnancy due to immunological, hormonal and respiratory changes. Approximately 1/3 of asthmatic women experience improved symptoms, 1/3 similar symptoms, and 1/3 worse symptoms. Factors like respiratory infections, obesity, and lack of medication adherence can increase risk of exacerbation. Proper asthma management and treatment is important to minimize risks to both mother and fetus.
Asthma in pregnancy
Topics covere
*difference b/w normal and asthmatic bronchi
*Triggering factors
* Respiratory changes during pregnancy
*Effects of asthma on pregnancy
* Pregnancy outcomes
* Clinical features
*Examination
*Management
*Complications
Asthma in Pregnancy
This document discusses asthma in pregnancy. It begins by introducing asthma as a common condition that affects approximately 8% of pregnant women. Left uncontrolled, asthma can increase risks of adverse pregnancy outcomes. The document then covers evaluation and diagnosis of asthma during pregnancy, including physical exams, symptoms, pulmonary function tests, and differentiating normal pregnancy dyspnea. It discusses management of asthma through education, monitoring, and medication including inhaled corticosteroids and beta-agonists. The goal of treatment is prevention of exacerbations to avoid risks to maternal and fetal health.
Asthma in pregnancy
1) Asthma affects approximately 4-8% of pregnant women. While pregnancy does not typically impair lung function, it can intensify the effects of lung diseases like asthma.
2) The pathophysiology of asthma involves chronic airway inflammation from factors like allergens, viruses, and environmental irritants. During pregnancy, changes in lung volumes and capacities can increase a woman's risk of hypoxia from asthma exacerbations.
3) For chronic asthma, treatment focuses on education, environmental control, and pharmacological therapy like inhaled corticosteroids and bronchodilators to maintain lung function. For acute exacerbations, therapy aims to quickly reverse bronchoconstriction and prevent
Asthma in pregnancy
- Asthma is characterized by airway inflammation and constriction caused by various triggers that vary between individuals. Common triggers include allergens, viruses, smoke, and exercise.
- The course of asthma during pregnancy is unpredictable, with symptoms improving in some, worsening in others, and no change in the remaining third. Poorly controlled asthma is associated with increased risks for complications.
- Most asthma medications are considered low risk during pregnancy and breastfeeding. Corticosteroids should not be withheld due to safety concerns. Acute asthma attacks during pregnancy require prompt treatment including oxygen, fluids, bronchodilators, and corticosteroids.
Astma in pregnancy
This document discusses the management of asthma during pregnancy. It notes that asthma is common in pregnancy, with respiratory changes occurring due to anatomical and hormonal factors. Pregnancy can affect asthma severity, with courses varying between women. Well controlled asthma is important for limiting risks to the pregnancy. Treatment follows a stepwise approach, initially using inhaled corticosteroids. Close monitoring is needed to prevent exacerbations while minimizing medication risks for the fetus. Inhaled beta-agonists are generally considered safe options for relief of symptoms during pregnancy.
Asthma in Pregnancy
This document discusses asthma in pregnancy. It defines asthma as a chronic inflammatory disease of the airways characterized by variable airflow limitation and respiratory symptoms. The prevalence of asthma in pregnancy ranges from 1-4%. The document outlines the risks of uncontrolled asthma in pregnancy, including preeclampsia, preterm birth, and low birth weight. It also covers the pathophysiology of asthma and how pregnancy affects respiratory physiology. Examination findings, differential diagnoses, diagnostic tests, treatment options, and management of asthma during pregnancy are discussed in detail.
Treating Asthma in Pregnancy
This document discusses the treatment of asthma during pregnancy. It emphasizes maintaining good asthma control through objective measurement, patient education, and proper medication adherence. Properly controlling asthma reduces risks to both the mother and developing baby. While some medications like inhaled corticosteroids are considered safe in pregnancy, treatment should be individualized and the benefits weighed against any potential risks. The goal is to prevent exacerbations through optimal management.
Asthma in Pregnancy
Asthma, breathing difficulty, pregnancy, shortness of breath, asthma medications, pregnancy, spirometry,
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
This document discusses asthma in pregnancy. It begins by defining asthma according to the WHO. It then discusses the pathophysiology of asthma and how pregnancy affects the respiratory system. It describes how to assess and monitor asthma severity using peak flow meters and spirometry. The document outlines different medication options for treating asthma during pregnancy, including quick relief medications like beta-agonists and long term control medications like inhaled corticosteroids. It discusses factors that influence asthma control and complications that can arise if asthma is not well-controlled during pregnancy.
Asthma in pregnancy
This document discusses asthma management during pregnancy. It begins by describing how pregnancy can affect asthma severity, noting that prior asthma severity predicts severity during pregnancy. It then explains how asthma can impact pregnancy outcomes like preterm delivery. The rest of the document covers general asthma care during pregnancy, including monitoring, education, trigger avoidance, and medications. It notes most asthma medications are category B or C but are generally considered safe in pregnancy with monitoring. Inhaled short-acting beta agonists are recommended for acute exacerbations. The goal is preventing acute episodes and optimizing lung function to reduce risks.
Asthma in Pregnancy
This summary reviews several studies on how asthma is affected during pregnancy. The studies show rates of asthma worsening from 14-41% of patients, unchanged in 26-43%, and
Bronchial asthama and pregnancys
This document discusses asthma, including its pathogenesis, triggers, symptoms, diagnosis and classification. It notes that asthma is a chronic inflammatory airway disease characterized by reversible bronchial constriction in response to multiple stimuli. Common symptoms include dyspnea, cough and wheezing. Diagnosis involves assessing symptoms, demonstrating reversibility of airflow obstruction via spirometry, and ruling out alternative diagnoses. Asthma is classified based on severity of symptoms and lung function.
Case Study On Asthma
Viral respiratory infections are a common trigger for acute asthma episodes. Viruses like rhinovirus can damage the airway and impair its defenses, making it more susceptible to inflammation. Early life wheezing from viruses is a risk factor for developing asthma. The sympathetic nervous system response to asthma involves adrenaline release and bronchodilation, but fails to fully reverse bronchoconstriction. James' symptoms relate to this sympathetic response. Salbutamol acts as a sympathomimetic drug by directly stimulating beta-2 receptors, mimicking the effects of adrenaline to induce bronchodilation. It was administered to James to help reverse bronchoconstriction from the asthma episode.
Presentation on pathogen of meningitis.siam (ppt file)
Meningitis is an inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It can be caused by various pathogens like bacteria and viruses. Common symptoms include high fever, headache, and neck stiffness. Treatment involves prompt administration of antibiotics depending on the causative organism. Prevention strategies include vaccination and avoiding sharing personal items that may spread pathogens.
2 genetic susceptibility to bronchial asthma
This lecture has been presented by DR.Hajer moaweia / Abusetta chest center in Global asthma day 2018.
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...amir mohammad Armanian
This study assessed the effects of aminophylline in reducing chronic lung disease (CLD) in very premature infants. 52 infants weighing 1200g or less were randomly assigned to receive aminophylline for the first 10 days (group A) or no aminophylline (group C). Infants receiving aminophylline had significantly shorter oxygen dependency times and lower incidence of CLD compared to the control group. Only 2 infants who received aminophylline developed CLD, compared to 11 infants in the control group. No side effects were reported from aminophylline. This study supports the preventative effects of aminophylline in reducing CLD in very premature infants.Asthma management phenotype based approach
Phenotypes and endotypes are approaches to classifying asthma subtypes based on clinical characteristics and underlying biological mechanisms. The document discusses several potential asthma endotypes including:
1) TH2-high endotypes like early-onset allergic asthma characterized by genetics predisposing to TH2 cytokines, biomarkers like elevated IgE and eosinophils, and response to anti-IgE therapy.
2) Late-onset eosinophilic asthma characterized by persistent sputum eosinophilia despite steroids and potential response to anti-IL5 therapy.
3) Aspirin-exacerbated respiratory disease which may be a similar endotype to intrinsic or allergic asthma due to acquired NSA
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Transient tachypnea of the newborn: What's new?
Pneumonia in children
This clinical guideline provides recommendations for diagnosing and treating pneumonia in children. Pneumonia is common in children under 2 years old and can be caused by bacteria, viruses, or mixed infections depending on the child's age. Clinical features like fever, cough, difficulty breathing, and fast breathing should prompt consideration of pneumonia. Chest x-rays are not needed for most cases but can help in complicated cases. Most children can be treated with oral antibiotics at home, while those with more severe symptoms require hospital admission and intravenous antibiotics. Complications like lung abscesses may occur and require longer treatment and follow up to ensure full recovery. Recurrent pneumonia may indicate underlying conditions that require further investigation.
Asthma and pregnancy
incidence and prevalence of asthma in pregnancy, guidelines for diagnosis and management of during pregnancy. drugs to be given and drugs to be avoided during pregnancy. pregnancy outcome in asthma patients.
Op RDS
This document discusses infant respiratory distress syndrome (IRDS), including its causes, signs and symptoms, diagnostic evaluation, treatment and nursing management. IRDS is caused by a lack of surfactant in premature infants' lungs. It can cause respiratory distress seen as tachypnea, retractions and grunting. Diagnosis involves blood tests and chest x-rays showing atelectasis. Treatment includes oxygen therapy, surfactant replacement, ventilation support and ensuring temperature and nutrition. Nursing care focuses on monitoring breathing and oxygen levels, preventing hypothermia and infection, and supporting nutrition and developmental care.
management of neonatal sepsis
This document discusses the management of neonatal sepsis and identifies areas of potential malpractice. It presents two case studies of neonates with sepsis that were potentially mismanaged. The document then outlines key topics to be covered, including features of neonatal sepsis, the role of CRP and procalcitonin in diagnosis, treatment planning considerations, controversies around certain drug uses, the role of blood exchange transfusions, and potential adjuvant therapies. Overall, the document aims to improve management of neonatal sepsis by revising basic knowledge around appropriate diagnosis and treatment.
Respiratory disorders in pregnancy
The document discusses the physiological changes that occur in the respiratory system during pregnancy. There is an increase in minute ventilation leading to respiratory alkalosis. Functional residual capacity decreases while vital capacity remains unchanged. Shortness of breath is common during pregnancy. Common respiratory conditions complicating pregnancy include asthma, tuberculosis, pneumonia, and influenza. Treatment for these conditions is largely similar to non-pregnant patients with some modifications due to safety.
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with CovidInternational Journal of Medical and Pharmaceutical Research
32-year-oldprimigravida, CATB2, Covid positive patient with acute onset of facial palsy, fever, sore throat and productive cough referred from a peripheral hospital came for caesarian section. Past history revealed occurrence of juvenile dermatomyositis for which she took steroids for one and a half year which was slowly weaned off. Prevalence of dermatomyositis is 1to 8 in 100,000. She was started on steroids which was to be continued for a week after caesarian section. She was on paracetamol and cefuroxime on admission. Basic investigations were normal. Caesarian section was done in covid theater following covid protocols under subarachnoid anesthesia Baby had an APGAR score of 9 and was covid negative. Mothers’ recovery was slow. Facial deviation got corrected in 4to 5 months. Ptosis persisted even after 9months and is on treatment. Dermatomyositis is an uncommon inflammatory disease that affects mainly proximal muscle limiting day to day activities. But it can affect respiratory, cardiac and gastrointestinal systems, eyes and joints. Diagnosis is by muscle biopsy and an increase in muscle enzymes. Pregnancy during remission period is safe. But pregnancy can provoke the disease. Skin changes usually precedes muscle symptoms, though we could not notify any lesions. Lung involvement is prominent, and covid also carries the same amount of risk with respiratory system. Systemic glucocorticoids are the first line of treatment. Immunosuppressant drugs Azathioprine and methotrexate are added as second line of therapy, though these drugs are unsafe during pregnancy. Intravenous immunoglobulin, give good outcome during pregnancy. Plasmapheresis is also beneficial. Most of the pregnant patients end up in caesariansection. Regionalanesthesia is the choice of anesthesia. Covid patients with respiratory infections, maintaining saturation above90%, choice of anesthesia is usually regional anesthesia.
Key Words: Juvenile Dermatomyositis, COVID, Cesarian Section
Respiratory distress in neonates
the common type of respiratory distress in newborn. To be in paeds, we have to understand these properly.
I tried my best to make proper presentation.
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
On December 25, 1642 a widow gave birth prematurely to a small baby boy who could fit in a quart mug. This baby survived and grew up to be Sir Isaac Newton, providing one of the earliest descriptions of preterm birth. Preterm birth, defined as birth between 28-36+6 weeks gestation, accounts for 5-10% of births and is a leading cause of perinatal morbidity and mortality. Multiple pathological processes can lead to preterm parturition, including ascending intrauterine infections. Tocolytic drugs are used to suppress uterine contractions and delay preterm delivery to allow for corticosteroid administration and transfer to facilities with neonatal intensive care. However, currently available tocolytics have poor
falla respiratoria.pdf
This review discusses acute respiratory failure in children. It aims to describe the physiologic peculiarities that make children more vulnerable to respiratory failure compared to adults. Some key points:
1) Acute respiratory failure is common in pediatric intensive care units and is usually caused by lung disease, airway disease, or inadequate respiratory effort.
2) Infant respiratory physiology increases susceptibility due to higher metabolism, immature breathing control, and more collapsible/compliant airways compared to adults.
3) Early recognition of respiratory failure is important through history and physical exam to identify the underlying cause and guide life-saving interventions before cardiopulmonary arrest occurs.
Respiratory Disorders In Pregnancy 26092023.pptx
This document discusses respiratory disorders that can occur during pregnancy. It begins by outlining the normal physiological changes to respiration that occur during pregnancy, including increased oxygen demand and changes in lung volume. It then examines specific pulmonary diseases like asthma, tuberculosis, influenza, and COVID-19 that can impact pregnant women. For each condition, it describes associated risks, symptoms, diagnosis, effects on pregnancy, and recommended treatment approaches. The goal is to understand how these respiratory disorders present during pregnancy and should be managed while considering the health and safety of both the mother and fetus.
More Related Content
What's hot
Treating Asthma in Pregnancy
This document discusses the treatment of asthma during pregnancy. It emphasizes maintaining good asthma control through objective measurement, patient education, and proper medication adherence. Properly controlling asthma reduces risks to both the mother and developing baby. While some medications like inhaled corticosteroids are considered safe in pregnancy, treatment should be individualized and the benefits weighed against any potential risks. The goal is to prevent exacerbations through optimal management.
Asthma in Pregnancy
Asthma, breathing difficulty, pregnancy, shortness of breath, asthma medications, pregnancy, spirometry,
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
This document discusses asthma in pregnancy. It begins by defining asthma according to the WHO. It then discusses the pathophysiology of asthma and how pregnancy affects the respiratory system. It describes how to assess and monitor asthma severity using peak flow meters and spirometry. The document outlines different medication options for treating asthma during pregnancy, including quick relief medications like beta-agonists and long term control medications like inhaled corticosteroids. It discusses factors that influence asthma control and complications that can arise if asthma is not well-controlled during pregnancy.
Asthma in pregnancy
This document discusses asthma management during pregnancy. It begins by describing how pregnancy can affect asthma severity, noting that prior asthma severity predicts severity during pregnancy. It then explains how asthma can impact pregnancy outcomes like preterm delivery. The rest of the document covers general asthma care during pregnancy, including monitoring, education, trigger avoidance, and medications. It notes most asthma medications are category B or C but are generally considered safe in pregnancy with monitoring. Inhaled short-acting beta agonists are recommended for acute exacerbations. The goal is preventing acute episodes and optimizing lung function to reduce risks.
Asthma in Pregnancy
This summary reviews several studies on how asthma is affected during pregnancy. The studies show rates of asthma worsening from 14-41% of patients, unchanged in 26-43%, and
Bronchial asthama and pregnancys
This document discusses asthma, including its pathogenesis, triggers, symptoms, diagnosis and classification. It notes that asthma is a chronic inflammatory airway disease characterized by reversible bronchial constriction in response to multiple stimuli. Common symptoms include dyspnea, cough and wheezing. Diagnosis involves assessing symptoms, demonstrating reversibility of airflow obstruction via spirometry, and ruling out alternative diagnoses. Asthma is classified based on severity of symptoms and lung function.
Case Study On Asthma
Viral respiratory infections are a common trigger for acute asthma episodes. Viruses like rhinovirus can damage the airway and impair its defenses, making it more susceptible to inflammation. Early life wheezing from viruses is a risk factor for developing asthma. The sympathetic nervous system response to asthma involves adrenaline release and bronchodilation, but fails to fully reverse bronchoconstriction. James' symptoms relate to this sympathetic response. Salbutamol acts as a sympathomimetic drug by directly stimulating beta-2 receptors, mimicking the effects of adrenaline to induce bronchodilation. It was administered to James to help reverse bronchoconstriction from the asthma episode.
Presentation on pathogen of meningitis.siam (ppt file)
Meningitis is an inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It can be caused by various pathogens like bacteria and viruses. Common symptoms include high fever, headache, and neck stiffness. Treatment involves prompt administration of antibiotics depending on the causative organism. Prevention strategies include vaccination and avoiding sharing personal items that may spread pathogens.
2 genetic susceptibility to bronchial asthma
This lecture has been presented by DR.Hajer moaweia / Abusetta chest center in Global asthma day 2018.
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...amir mohammad Armanian
This study assessed the effects of aminophylline in reducing chronic lung disease (CLD) in very premature infants. 52 infants weighing 1200g or less were randomly assigned to receive aminophylline for the first 10 days (group A) or no aminophylline (group C). Infants receiving aminophylline had significantly shorter oxygen dependency times and lower incidence of CLD compared to the control group. Only 2 infants who received aminophylline developed CLD, compared to 11 infants in the control group. No side effects were reported from aminophylline. This study supports the preventative effects of aminophylline in reducing CLD in very premature infants.Asthma management phenotype based approach
Phenotypes and endotypes are approaches to classifying asthma subtypes based on clinical characteristics and underlying biological mechanisms. The document discusses several potential asthma endotypes including:
1) TH2-high endotypes like early-onset allergic asthma characterized by genetics predisposing to TH2 cytokines, biomarkers like elevated IgE and eosinophils, and response to anti-IgE therapy.
2) Late-onset eosinophilic asthma characterized by persistent sputum eosinophilia despite steroids and potential response to anti-IL5 therapy.
3) Aspirin-exacerbated respiratory disease which may be a similar endotype to intrinsic or allergic asthma due to acquired NSA
What's hot (11)
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Asthma in pregnancy Dr Muhammad Akram Khan Qaim Khani
Presentation on pathogen of meningitis.siam (ppt file)
Presentation on pathogen of meningitis.siam (ppt file)
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Reducing the Incidence of Chronic Lung Disease in Very Premature Infants with...
Similar to Tanl power point
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Transient tachypnea of the newborn: What's new?
Pneumonia in children
This clinical guideline provides recommendations for diagnosing and treating pneumonia in children. Pneumonia is common in children under 2 years old and can be caused by bacteria, viruses, or mixed infections depending on the child's age. Clinical features like fever, cough, difficulty breathing, and fast breathing should prompt consideration of pneumonia. Chest x-rays are not needed for most cases but can help in complicated cases. Most children can be treated with oral antibiotics at home, while those with more severe symptoms require hospital admission and intravenous antibiotics. Complications like lung abscesses may occur and require longer treatment and follow up to ensure full recovery. Recurrent pneumonia may indicate underlying conditions that require further investigation.
Asthma and pregnancy
incidence and prevalence of asthma in pregnancy, guidelines for diagnosis and management of during pregnancy. drugs to be given and drugs to be avoided during pregnancy. pregnancy outcome in asthma patients.
Op RDS
This document discusses infant respiratory distress syndrome (IRDS), including its causes, signs and symptoms, diagnostic evaluation, treatment and nursing management. IRDS is caused by a lack of surfactant in premature infants' lungs. It can cause respiratory distress seen as tachypnea, retractions and grunting. Diagnosis involves blood tests and chest x-rays showing atelectasis. Treatment includes oxygen therapy, surfactant replacement, ventilation support and ensuring temperature and nutrition. Nursing care focuses on monitoring breathing and oxygen levels, preventing hypothermia and infection, and supporting nutrition and developmental care.
management of neonatal sepsis
This document discusses the management of neonatal sepsis and identifies areas of potential malpractice. It presents two case studies of neonates with sepsis that were potentially mismanaged. The document then outlines key topics to be covered, including features of neonatal sepsis, the role of CRP and procalcitonin in diagnosis, treatment planning considerations, controversies around certain drug uses, the role of blood exchange transfusions, and potential adjuvant therapies. Overall, the document aims to improve management of neonatal sepsis by revising basic knowledge around appropriate diagnosis and treatment.
Respiratory disorders in pregnancy
The document discusses the physiological changes that occur in the respiratory system during pregnancy. There is an increase in minute ventilation leading to respiratory alkalosis. Functional residual capacity decreases while vital capacity remains unchanged. Shortness of breath is common during pregnancy. Common respiratory conditions complicating pregnancy include asthma, tuberculosis, pneumonia, and influenza. Treatment for these conditions is largely similar to non-pregnant patients with some modifications due to safety.
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with CovidInternational Journal of Medical and Pharmaceutical Research
32-year-oldprimigravida, CATB2, Covid positive patient with acute onset of facial palsy, fever, sore throat and productive cough referred from a peripheral hospital came for caesarian section. Past history revealed occurrence of juvenile dermatomyositis for which she took steroids for one and a half year which was slowly weaned off. Prevalence of dermatomyositis is 1to 8 in 100,000. She was started on steroids which was to be continued for a week after caesarian section. She was on paracetamol and cefuroxime on admission. Basic investigations were normal. Caesarian section was done in covid theater following covid protocols under subarachnoid anesthesia Baby had an APGAR score of 9 and was covid negative. Mothers’ recovery was slow. Facial deviation got corrected in 4to 5 months. Ptosis persisted even after 9months and is on treatment. Dermatomyositis is an uncommon inflammatory disease that affects mainly proximal muscle limiting day to day activities. But it can affect respiratory, cardiac and gastrointestinal systems, eyes and joints. Diagnosis is by muscle biopsy and an increase in muscle enzymes. Pregnancy during remission period is safe. But pregnancy can provoke the disease. Skin changes usually precedes muscle symptoms, though we could not notify any lesions. Lung involvement is prominent, and covid also carries the same amount of risk with respiratory system. Systemic glucocorticoids are the first line of treatment. Immunosuppressant drugs Azathioprine and methotrexate are added as second line of therapy, though these drugs are unsafe during pregnancy. Intravenous immunoglobulin, give good outcome during pregnancy. Plasmapheresis is also beneficial. Most of the pregnant patients end up in caesariansection. Regionalanesthesia is the choice of anesthesia. Covid patients with respiratory infections, maintaining saturation above90%, choice of anesthesia is usually regional anesthesia.
Key Words: Juvenile Dermatomyositis, COVID, Cesarian Section
Respiratory distress in neonates
the common type of respiratory distress in newborn. To be in paeds, we have to understand these properly.
I tried my best to make proper presentation.
MANAGEMENT OF PRETERM LABOUR:ATOSIBAN
On December 25, 1642 a widow gave birth prematurely to a small baby boy who could fit in a quart mug. This baby survived and grew up to be Sir Isaac Newton, providing one of the earliest descriptions of preterm birth. Preterm birth, defined as birth between 28-36+6 weeks gestation, accounts for 5-10% of births and is a leading cause of perinatal morbidity and mortality. Multiple pathological processes can lead to preterm parturition, including ascending intrauterine infections. Tocolytic drugs are used to suppress uterine contractions and delay preterm delivery to allow for corticosteroid administration and transfer to facilities with neonatal intensive care. However, currently available tocolytics have poor
falla respiratoria.pdf
This review discusses acute respiratory failure in children. It aims to describe the physiologic peculiarities that make children more vulnerable to respiratory failure compared to adults. Some key points:
1) Acute respiratory failure is common in pediatric intensive care units and is usually caused by lung disease, airway disease, or inadequate respiratory effort.
2) Infant respiratory physiology increases susceptibility due to higher metabolism, immature breathing control, and more collapsible/compliant airways compared to adults.
3) Early recognition of respiratory failure is important through history and physical exam to identify the underlying cause and guide life-saving interventions before cardiopulmonary arrest occurs.
Respiratory Disorders In Pregnancy 26092023.pptx
This document discusses respiratory disorders that can occur during pregnancy. It begins by outlining the normal physiological changes to respiration that occur during pregnancy, including increased oxygen demand and changes in lung volume. It then examines specific pulmonary diseases like asthma, tuberculosis, influenza, and COVID-19 that can impact pregnant women. For each condition, it describes associated risks, symptoms, diagnosis, effects on pregnancy, and recommended treatment approaches. The goal is to understand how these respiratory disorders present during pregnancy and should be managed while considering the health and safety of both the mother and fetus.
Bronchopulmonary dysplasia updates_and_prevention dr falakha
The document discusses bronchopulmonary dysplasia (BPD) and strategies for prevention. It notes that BPD results from disrupted alveolar development and remodeling of the airways, vasculature, and smooth muscle. Risk factors include prematurity, genetics, chorioamnionitis, and exposures associated with resuscitation and mechanical ventilation. Strategies discussed to prevent BPD include using lower oxygen concentrations during resuscitation, applying continuous positive airway pressure, and avoiding overinflation and atelectrauma through gentle ventilation techniques. Future research is still needed to develop more evidence-based prevention and treatment approaches for BPD.
RDS-.pptx
Respiratory distress is common in preterm infants and can have serious consequences. It is defined as the presence of tachypnea, retractions, or grunting. Common causes include respiratory distress syndrome (RDS) due to surfactant deficiency. Assessment involves evaluating respiratory rate, work of breathing, oxygen needs and chest x-ray findings. Management consists of supportive care including oxygen supplementation, monitoring, antibiotics if indicated. Surfactant replacement therapy improves outcomes in RDS but can increase risk of apnea. Non-invasive respiratory support with CPAP is preferred over mechanical ventilation when possible.
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...Ruth Vargas Gonzales
1) A new strain of influenza A virus (H1N1) emerged and spread rapidly globally, increasing concern as it disproportionately affected young people. Pregnant women are also at high risk.
2) The antiviral drugs oseltamivir and zanamivir are effective against the new H1N1 strain. Limited data suggests oseltamivir is unlikely to cause major birth defects, while even less is known about zanamivir's safety during pregnancy.
3) Both drugs are considered compatible with breastfeeding as levels transferred to breastmilk would be low. Continued breastfeeding is recommended even if the mother is being treated.ROP prevention at NICU.pptx
Overall care of newborn should be improved to prevent Retinopathy of Prematurity (ROP). Timely screening is very important to prevent blindness.
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...amir mohammad Armanian
1. The study assessed the prophylactic effects of aminophylline on apnea in preterm neonates with a gestational age less than 32 weeks and/or birth weight less than 1200g.
2. 52 neonates were randomly assigned to receive either aminophylline (group A) or no aminophylline (group C) for the first 10 days.
3. Primary outcomes like apnea, bradycardia and cyanosis were significantly lower in the aminophylline group compared to the control group. Secondary outcomes like need for CPAP and length of hospital stay were also lower in the aminophylline group.Respiratory Failure in the Pregnant Patient
Lecture presented by Dr Mohamed Khaled at the Egyptian African Critical Care Summit 2017 held at Cairo, Egypt
Dizdar et al., 2011
This study compared the efficacy of two animal-derived surfactants, poractant alfa and beractant, in treating respiratory distress syndrome (RDS) in preterm infants. The study found that infants treated with poractant alfa required significantly less oxygen in the first 5 days after treatment compared to those treated with beractant. Infants in the poractant alfa group also had higher rates of extubation within 3 days. Additionally, poractant alfa treatment resulted in fewer infants requiring multiple doses of surfactant compared to beractant treatment. While mortality and other outcomes were similar between groups, survival without bronchopulmonary dysplasia at the end of the study period was significantly higher
seminar on bronco pulmonary dysplasia
This document provides an outline for a presentation on bronchopulmonary dysplasia (BPD). It begins with an introduction defining BPD and its increasing prevalence in preterm infants. The outline then covers the definition, epidemiology, risk factors including prematurity, lung injury from mechanical ventilation and oxygen toxicity, pathophysiology involving disrupted lung development, clinical presentation with respiratory symptoms, and management approaches to prevent and treat BPD.
Neonatal sepsis
Neonatal sepsis occurs when pathogenic organisms enter the bloodstream of newborns, potentially causing infections like septicemia, pneumonia, or meningitis. Worldwide it accounts for 15% of neonatal deaths. In Nepal, neonatal sepsis causes 47.7% of neonatal deaths. It can be early onset within 3 days of life due to maternal infections, or late onset after 3 days from hospital-acquired infections. Common causes are E. coli, Staphylococcus aureus, and Klebsiella. Risk factors include prematurity, low birth weight, maternal infections, and lack of breastfeeding. Symptoms include pallor, apnea, bulging fontanel, and poor feeding. Diagnosis involves sepsis
Similar to Tanl power point (20)
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Taquipnea transitoria del recién nacido: Que hay de nuevo?
Pregnancy in Dermatomyositis Complicated with Covid
Pregnancy in Dermatomyositis Complicated with Covid
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Safety of neuraminidase inhibitors in pregnant and breastfeeding women tanaka...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neo...
Recently uploaded
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Aberdeen
A Visual Guide to 1 Samuel | A Tale of Two Hearts
These slides walk through the story of 1 Samuel. Samuel is the last judge of Israel. The people reject God and want a king. Saul is anointed as the first king, but he is not a good king. David, the shepherd boy is anointed and Saul is envious of him. David shows honor while Saul continues to self destruct.
Educational Technology in the Health Sciences
Plenary presentation at the NTTC Inter-university Workshop, 18 June 2024, Manila Prince Hotel.
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...Nguyen Thanh Tu Collection
https://app.box.com/s/qhtvq32h4ybf9t49ku85x0n3xl4jhr15Temple of Asclepius in Thrace. Excavation results
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
HYPERTENSION - SLIDE SHARE PRESENTATION.
IT WILL BE HELPFULL FOR THE NUSING STUDENTS
IT FOCUSED ON MEDICAL MANAGEMENT AND NURSING MANAGEMENT.
HIGHLIGHTS ON HEALTH EDUCATION.
Stack Memory Organization of 8086 Microprocessor
The stack memory organization of 8086 microprocessor.
Wound healing PPT
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh
Recently uploaded (20)
SWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptx
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Tanl power point
- 5. Percentage of Term and Preterm newborn Total 30 patients: Boys 20(67%) & Girls 10(30%) 5
- 6. Body weight of patients
- 7. Pathologic events in RDS Rosario N. Santos--Chua, et al , UpToDate , 2009.
- 8. Investigation of Respiratory Distress Syndrome in newborn
- 11. 11
- 13. Surfactant therapy Alveofact, Curosurf, Infasurg, Survanta Curosurf Dosage: Intratracheal: Initial: 2.5 mL/kg/dose (200 mg/kg/dose); may repeat 1.25 mL/kg/dose (100 mg/kg/dose); at 12-hour intervals for up to 2 additional doses; maximum total dose: 5 mL/kg. Curosurf It produces rapid improvements in lung oxygenation and compliance that may require immediate reductions in ventilator settings and FiO2.
- 14. Surfactant versus placebo treatment from Liechty EA; et al, July 1991.
- 15. Differences between the percentage of following cases in Newborn’s Department and NICU
- 16. Antibiotic usage for newborn’s 3 diseases in following department *3 diseases are Aspiration pneumonia, Respiratory distress syndrome & Congenital pneumonia. Pt.no= Patient’s number Pt.no Pt.no Pt.no Antibiotics in NICU (N=21) Antibiotics in Newborn Department (N=9) Antibiotics in Newborn department after treated from NICU (N=21) Netilmicin ( Нетилмицин ) 13 Cefotaxime (Клафоран) 8 Ceftriaxone 10 Ceftriaxone ( Роцефин ) 13 Fluconazole 2 Ciprofloxacin 8 Ciprofloxacin ( Ципробай ) 10 Amikacin 1 Fluconazole 7 Vancomycin ( Ванкомицин ) 6 Netilmicin 4 Fluconazole ( Дифлюкан ) 6 Vancomycin 2 Metronidazole (Метрогил) 5 Metronidazole 2 Ceftazidime (Фортум) 4 Ceftazidime 1 Rifampicin (Рифампицин) 3 Imipenem (Имипенем) 1 Amikacin (Амикацин) 3 Imipenem+Cilastatin (Тиенам) 1 Linezolide (Линизолед) 1
- 17. Differences between antibiotics combination in Newborn Department, Newborn Department after treated from NICU and NICU
- 18. Combine antibiotic treatment according to following diseases
- 19. CPAP and Mechanical Ventilation
- 20. Duration of stay in Neonatal Intensive Care Unit and Newborn’s department NICU Newborn’s department duration 20